Technology

The TLS3 Tissue Ligating Shears feature Starion�s proprietary thermal welding technology, focusing thermal energy to ...

Home February 20, 2008
Home
Technology

Point-of-care blood analysis systems company Abaxis Inc. said the FDA granted waived status for its comprehensive metabolic panel, basic metabolic panel and electrolyte panel, allowing lab-accurate comprehensive health screenings in nearly any environment.

Home February 20, 2008
Home
Technology

Cardinal Health and HemCon Medical Technologies Inc. in December announced the availability of co-labeled chitosan-based ...

Home February 20, 2008
Home
Technology

W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.

Home February 19, 2008
Home
Technology

Toshiba America Medical Systems Inc. recently introduced its Infinix VF-i/SP X-ray system, a universal cardiovascular ...

Home February 19, 2008
Home
28539_1
Feature | Dave Fornell

February 2008 - The traditional hospital cleaning methods of wiping down surfaces and mopping floors are now being ...

Home February 19, 2008
Home
Technology

The ACUSON X300 works to provide compact, portable color Doppler solutions for adult, pediatric, OR, EP and ...

Home February 19, 2008
Home
News

February 20, 2008 - Philips Medical Systems features at HIMSS 2008 enhancements to its speech recognition solution ...

Home February 19, 2008
Home
Technology

Siemens Medical Solutions received FDA 510(k) clearance for a 1.5T magnetic resonance imaging (MRI) system that is ...

Home February 19, 2008
Home
News

February 20, 2008 - At HIMSS 2008, Siemens Healthcare will emphasize its image data management solutions for radiology ...

Home February 19, 2008
Home
News

February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.

Home February 18, 2008
Home
News

February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15. The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.

Home February 18, 2008
Home
News

February 19, 2008 – The American College of Cardiology (ACC) urges the medical community to oppose cuts to medical ...

Home February 18, 2008
Home
News

February 19, 2008 - Boston Scientific Corp. closed the sale of its Fluid Management and Venous Access businesses to ...

Home February 18, 2008
Home
News

February 19, 2008 - A new study released today found pending congressional legislation seeking the mandatory disclosure ...

Home February 18, 2008
Home
Subscribe Now